12:00 AM
 | 
Feb 11, 2013
 |  BC Week In Review  |  Company News  |  Other News

Boehringer Ingelheim pharmaceuticals news

The U.S. District Court for the Northern District of Ohio approved a consent decree of permanent injunction restraining Boehringer's Ben Venue Laboratories Inc. company from manufacturing and distributing drugs from its Bedford, Ohio, facility until FDA determines that its operations are compliant with the...

Read the full 200 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >